resveratrol has been researched along with Glioma in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (33.33) | 29.6817 |
| 2010's | 24 (50.00) | 24.3611 |
| 2020's | 8 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, W; Kong, D; Li, Y; Ying, X; Yu, M; Zheng, Y | 1 |
| Ghazwani, M; Gowda, DV; Gurupadayya, BM; Hani, U; Hemanth Vikram, PR; Osmani, RAM; Sathishbabu, P; Shakeela, C | 1 |
| Mertoğlu Kamalı, E; Önay Uçar, E; Şengelen, A | 1 |
| Bagheri, H; Bahman, Y; Moliani, A; Mousavi, M; Zhang, Y; Zhang, Z | 1 |
| Li, PCH; Rahimi, A; Sharifi, H | 1 |
| Büsselberg, D; Kassayova, M; Kiskova, T; Kubatka, P | 1 |
| Adiga, D; Afzal, S; Garg, S; Ishida, Y; Kaul, SC; Terao, K; Wadhwa, R | 1 |
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Aschner, M; Dadgostar, E; Fallah, M; Heidari-Soureshjani, R; Izadfar, F; Mirzaei, H; Tamtaji, OR | 1 |
| Baer-Dubowska, W; Kaczmarek, M; Krajka-Kuźniak, V; Zielińska-Przyjemska, M; Łuczak, M | 1 |
| Gerdes, BC; Koulen, P; Means, JC | 1 |
| Dong, J; Fei, X; Hong, L; Huang, Q; Ma, J; Meng, X; Qin, R; Wang, A; Wang, D; Wang, Z | 1 |
| Bu, XY; Gao, YS; Han, SY; Hu, S; Qu, MQ; Wang, BQ; Wang, JY; Yan, ZY; Yang, B; Yang, HC | 1 |
| Battastini, AM; Bernardi, A; Edelweiss, MI; Figueiró, F; Frozza, RL; Guterres, SS; Jandrey, EH; Moreira, JC; Pohlmann, AR; Salbego, CG; Terroso, T; Zanotto-Filho, A | 1 |
| Kayama, T; Kitanaka, C; Narita, Y; Okada, M; Sato, A; Seino, S; Shibui, S; Shibuya, K; Suzuki, K; Watanabe, E | 1 |
| Dai, H; Guo, W; Jia, Z; Li, A; Li, H; Yuan, Y | 1 |
| Bonatto, D; Filippi-Chiela, EC; Kipper, FC; Lenz, G; Suhre, T; Vargas, JE | 1 |
| Bayer, H; Danzer, KM; Eschbach, J; Fauler, M; Liss, B; Ludolph, AC; McLean, PJ; Morrison, BE; Müller, K; Otto, M; Rudolph, KL; Scheffold, A; Spada, AR; Thal, DR; von Einem, B; Weishaupt, JH; Weydt, P; Witting, A | 1 |
| Jiang, J; Jiang, X; Liu, Q; Qiu, G; Sun, S; Xu, S; Yu, W; Zhuo, F | 1 |
| Dai, F; Huang, Q; Jia, Z; Jiang, H; Kang, C; Pu, P; Wang, G; Yu, K; Zhang, A | 1 |
| Cui, J; Li, H; Overstreet, AM; Shan, D; Wang, Y; Xu, ZD; Xue, F; Yang, Y; Yu, C; Zhan, Y; Zhang, M | 1 |
| Cho, GJ; Choi, J; Choi, WS; Jeong, JY; Kang, S; Kang, SS; Kim, HJ; Lee, DH; Park, JW; Park, JY; Park, N; Roh, GS; Ryu, J; Seong, H; Yoon, NA | 1 |
| Feng, H; Wang, H; Zhang, Y | 1 |
| Bazzoni, R; Bentivegna, A; Butta, V; Cadamuro, M; Cilibrasi, C; Dalprà, L; Giovannoni, R; Lavitrano, M; Paoletta, L; Riva, G; Romano, G; Strazzabosco, M | 1 |
| Fu, Z; Hu, Y; Jiang, C; Li, Q; Li, X; Lu, X; Shao, J; You, Y | 1 |
| Dillenburg-Pilla, P; Filippi-Chiela, EC; Horn, F; Lenz, G; Salbego, C; Zamin, LL | 1 |
| de Souza, DF; Gelain, DP; Gonçalves, CA; Gottfried, C; Latini, A; Moreira, JC; Nardin, P; Quincozes-Santos, A | 1 |
| Li, J; Liang, Z; Qin, Z | 1 |
| Feng, X; Lin, N; Liu, H; Luo, Z; Wang, J; Xu, X; Zhang, B | 1 |
| Al-Holou, S; Chopp, M; Gautam, SC; Huang, G; Jiang, H; Shang, X; Wang, Y; Wu, H | 1 |
| Al-Holou, S; Chopp, M; Gautam, SC; Jiang, H; Kuo, J; Li, C; Shang, X; Wu, H; Zhang, L | 1 |
| Aldini, G; Colombo, G; Colombo, R; Dalle-Donne, I; Gagliano, N; Gioia, M; Milzani, A; Rossi, R | 1 |
| Basso, E; Cornetta, T; Cozzi, R; Leone, S | 1 |
| Diah, S; Fei, Z; Kawai, N; Matsumoto, K; Miyake, K; Murao, K; Okada, M; Tamiya, T; Zhang, W; Zhang, X | 1 |
| Aluigi, MG; Calzia, D; Morelli, A; Panfoli, I; Ramoino, P; Ravera, S | 1 |
| Barnett, TL; Gao, Z; Xu, CW; Xu, MS | 1 |
| Lee, CC; Lin, CJ; Lin, TY; Lin, YF; Shih, CM; Shih, YL; Wang, SH | 1 |
| Basso, E; Cozzi, R; Leone, S; Polticelli, F | 1 |
| Cho, GJ; Choi, J; Choi, WS; Jeong, JY; Kang, S; Kang, SS; Kim, HJ; Kim, N; Ku, BM; Lee, DH; Lee, YK; Roh, GS; Ryu, J; Yang, Y | 1 |
| Chen, CK; Chen, JC; Chen, Y; Huang, HY; Lin, PY; Lin, SM; Su, YH; Tseng, SH | 1 |
| Corcoran, GB; Gautam, SC; Groc, L; Hunter, TJ; Jiang, H; Koubi, D; Kuo, J; Kuo, K; Levine, RA; Rodriguez, AI; Seidman, MD; Zhang, L | 1 |
| Arimochi, H; Morita, K | 1 |
| Choi, BT; Choi, YH; Kim, CH; Kim, YA; Lee, SJ; Lim, SY; Park, KY; Park, YM; Rhee, SH | 1 |
| Chovolou, Y; Kahl, R; Kampkötter, A; Michels, G; Niering, P; Proksch, P; Wätjen, W; Weber, N | 1 |
| de Almeida, LM; dos Santos, AQ; Funchal, C; Gonçalves, CA; Gottfried, C; Jacques-Silva, MC; Nardin, P; Wofchuk, ST | 1 |
| Fei, Z; Zhang, JN; Zhang, W; Zhang, X; Zhen, HN | 1 |
| Andreazza, AC; Funchal, C; Gonçalves, CA; Gottfried, C; Nardin, P; Quincozes-Santos, A | 1 |
| Davis, FB; Davis, PJ; Hammond, D; Hercbergs, A; Keating, T; Lin, HY; Shih, A; Sun, M; Tang, HY; Wu, YH | 1 |
3 review(s) available for resveratrol and Glioma
| Article | Year |
|---|---|
The Plant-Derived Compound Resveratrol in Brain Cancer: A Review.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biological Availability; Brain; Brain Neoplasms; Drug Resistance, Neoplasm; Glioma; Humans; Resveratrol; Signal Transduction | 2020 |
Therapeutic Potential of Resveratrol in the Treatment of Glioma: Insights into its Regulatory Mechanisms.
Topics: Apoptosis; Autophagy; Cell Cycle Checkpoints; Flavonoids; Glioma; Humans; Resveratrol | 2021 |
The potential of resveratrol against human gliomas.
Topics: Antineoplastic Agents; Brain Neoplasms; Glioma; Humans; Resveratrol; Ribonucleotide Reductases; Stilbenes | 2010 |
1 trial(s) available for resveratrol and Glioma
44 other study(ies) available for resveratrol and Glioma
| Article | Year |
|---|---|
Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas.
Topics: Animals; Brain; Cell Line, Tumor; Epirubicin; Glioma; Humans; Liposomes; Rats; Resveratrol | 2022 |
A novel RP-HPLC method development and validation for simultaneous quantification of gefitinib and resveratrol in polymeric hybrid lipid nanoparticles and glioma cells.
Topics: Chromatography, High Pressure Liquid; Gefitinib; Glioma; Humans; Polymers; Resveratrol | 2022 |
Hsp27, Hsp60, Hsp70, or Hsp90 depletion enhances the antitumor effects of resveratrol via oxidative and ER stress response in human glioblastoma cells.
Topics: Endoplasmic Reticulum Stress; Glioblastoma; Glioma; Heat-Shock Proteins; HEK293 Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Oxidative Stress; Reactive Oxygen Species; Resveratrol; RNA, Small Interfering | 2023 |
Resveratrol inhibits glioblastoma cells and chemoresistance progression through blockade P-glycoprotein and targeting AKT/PTEN signaling pathway.
Topics: ATP Binding Cassette Transporter, Subfamily B; Brain Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction | 2023 |
Cytosolic Calcium Measurement Utilizing a Single-Cell Biochip to Study the Effect of Curcumin and Resveratrol on a Single Glioma Cell.
Topics: Calcium; Curcumin; Cytosol; Glioma; Humans; Resveratrol | 2023 |
Anti-stress, Glial- and Neuro-differentiation Potential of Resveratrol: Characterization by Cellular, Biochemical and Imaging Assays.
Topics: Aging; Animals; Antioxidants; Astrocytes; Brain; Cell Line, Tumor; Cellular Reprogramming; DNA Damage; Dose-Response Relationship, Drug; Environmental Exposure; Glioma; Humans; Neuroblastoma; Neurons; Oxidative Stress; Rats; Resveratrol | 2020 |
The effect of resveratrol, its naturally occurring derivatives and tannic acid on the induction of cell cycle arrest and apoptosis in rat C6 and human T98G glioma cell lines.
Topics: Adjuvants, Pharmaceutic; Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioma; Humans; Membrane Potential, Mitochondrial; Rats; Resveratrol; Stilbenes; Tannins | 2017 |
Distinct Mechanisms Underlying Resveratrol-Mediated Protection from Types of Cellular Stress in C6 Glioma Cells.
Topics: Animals; Apoptosis; Caspases; Cell Line, Tumor; Cytoprotection; DNA Damage; Enzyme Activation; Glioma; Models, Biological; Neurofibrillary Tangles; Oxidative Stress; Phosphorylation; Phosphoserine; Rats; Resveratrol; Signal Transduction; Stilbenes; Stress, Physiological; tau Proteins; Ultraviolet Rays | 2017 |
Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Cisplatin; Coculture Techniques; Dendritic Cells; Female; Glioma; Humans; Luminescent Proteins; Male; Mice, Nude; Mice, Transgenic; Neoplastic Stem Cells; Resveratrol; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Glycogen Synthase Kinase 3 beta; Humans; Mice; Mice, Nude; O(6)-Methylguanine-DNA Methyltransferase; Resveratrol; Temozolomide; Wnt Signaling Pathway | 2019 |
Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemical Phenomena; Chemistry, Pharmaceutical; Disease Models, Animal; G1 Phase; Glioma; Hippocampus; Humans; Lipids; Male; Nanocapsules; Neoplasm Transplantation; Rats; Rats, Wistar; Resveratrol; S Phase; Solutions; Stilbenes; Tumor Burden | 2013 |
Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.
Topics: Animals; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Gene Silencing; Glioma; Homeodomain Proteins; Humans; Male; Mice; Mice, Inbred BALB C; Nanog Homeobox Protein; Neoplastic Stem Cells; Proteasome Endopeptidase Complex; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes; Transfection; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2013 |
Transferrin modified PEG-PLA-resveratrol conjugates: in vitro and in vivo studies for glioma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Brain; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Glioma; Lactic Acid; Male; Molecular Targeted Therapy; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers; Rats; Resveratrol; Stilbenes; Survival Analysis; Transferrin; Xenograft Model Antitumor Assays | 2013 |
Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells.
Topics: Animals; Antineoplastic Agents; Butyric Acid; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Drug Screening Assays, Antitumor; Drug Synergism; Glioma; Histone Deacetylase Inhibitors; Humans; Quercetin; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes | 2014 |
Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Animals; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Female; Gene Expression Regulation; Glioma; Humans; Macrolides; Male; Mice; Mice, Transgenic; Middle Aged; Neurons; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Resveratrol; RNA Polymerase II; Stilbenes; Substantia Nigra; TATA-Box Binding Protein; Transcription Factors | 2015 |
Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; DNA Damage; Doxorubicin; Glioma; Humans; Necrosis; Resveratrol; RNA, Long Noncoding; Stilbenes | 2015 |
Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Glioma; MicroRNAs; Rats; Resveratrol; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays | 2015 |
Resveratrol Represses Pokemon Expression in Human Glioma Cells.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cellular Senescence; DNA-Binding Proteins; DNA, Neoplasm; E1A-Associated p300 Protein; Gene Expression Regulation, Neoplastic; Glioma; HEK293 Cells; Histone Deacetylase 1; Humans; Promoter Regions, Genetic; Protein Binding; Protein Transport; Resveratrol; Sp1 Transcription Factor; Stilbenes; Transcription Factors | 2016 |
Resveratrol Induces Glioma Cell Apoptosis through Activation of Tristetraprolin.
Topics: 3' Untranslated Regions; Apoptosis; AU Rich Elements; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Fibroblasts; Gene Expression Regulation; Glioma; Humans; Receptors, Urokinase Plasminogen Activator; Resveratrol; RNA Stability; RNA, Messenger; Stilbenes; Tristetraprolin; Up-Regulation; Urokinase-Type Plasminogen Activator | 2015 |
Resveratrol inhibits hypoxia-induced glioma cell migration and invasion by the p-STAT3/miR-34a axis.
Topics: Cell Line, Tumor; Cell Movement; Gene Expression Regulation, Neoplastic; Glioma; Humans; Hypoxia; Resveratrol; STAT3 Transcription Factor; Up-Regulation | 2016 |
Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
Topics: beta Catenin; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; Glioma; Humans; Neoplastic Stem Cells; Proto-Oncogene Proteins c-myc; Resveratrol; Stilbenes; Wnt Signaling Pathway | 2017 |
Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels.
Topics: Animals; Biodegradation, Environmental; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Glioma; Intracellular Space; Microscopy, Fluorescence; Nanoparticles; Particle Size; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Vitamin E | 2009 |
Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells.
Topics: Aging; Animals; Animals, Newborn; Anticarcinogenic Agents; Antioxidants; Apoptosis; Astrocytes; Caspases; Colony-Forming Units Assay; Drug Combinations; Drug Synergism; Glioma; Humans; Immunoblotting; Mice; Quercetin; Rats; Rats, Wistar; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2009 |
The janus face of resveratrol in astroglial cells.
Topics: Actins; Analysis of Variance; Animals; Antioxidants; Astrocytes; Dose-Response Relationship, Drug; Drug Interactions; Electrophoretic Mobility Shift Assay; Glioma; Glutamate-Ammonia Ligase; Glutamic Acid; Glutathione; Hydrogen Peroxide; Nerve Growth Factors; NF-kappa B; Oxidants; Phorbol Esters; Propidium; Rats; Reactive Oxygen Species; Resveratrol; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Stilbenes | 2009 |
The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Glioma; Humans; Membrane Potentials; Microscopy, Fluorescence; Mitochondrial Membranes; Resveratrol; Stilbenes; Tetrazolium Salts; Thiazoles | 2009 |
[Suppressive effect of resveratrol on growth of U251 human glioma cells and its correlated mechanism].
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Caspase 3; Cell Line, Tumor; Cyclin D1; Gene Expression Regulation, Neoplastic; Glioma; Humans; Immunohistochemistry; Proto-Oncogene Proteins c-bcl-2; Resveratrol; STAT3 Transcription Factor; Stilbenes | 2009 |
Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Isothiocyanates; Resveratrol; Stilbenes; Sulfoxides; Thiocyanates | 2010 |
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells.
Topics: Antineoplastic Agents, Phytogenic; Caspase 3; Cell Line, Tumor; Cyclin D1; Dose-Response Relationship, Drug; Down-Regulation; Glioma; Humans; Phosphoinositide-3 Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2009 |
Resveratrol induces DNA double-strand breaks through human topoisomerase II interaction.
Topics: Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Glioma; Histones; Humans; Phosphorylation; Resveratrol; Stilbenes; Topoisomerase II Inhibitors | 2010 |
Resveratrol represses YKL-40 expression in human glioma U87 cells.
Topics: Adipokines; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitinase-3-Like Protein 1; Culture Media; Disease-Free Survival; Gene Expression Regulation, Neoplastic; Glioma; Glycoproteins; Humans; Lectins; Prognosis; Promoter Regions, Genetic; Recurrence; Resveratrol; Stilbenes | 2010 |
Evidence for ectopic aerobic ATP production on C6 glioma cell plasma membrane.
Topics: Adenosine Triphosphate; Aerobiosis; Animals; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Respiration; Electron Transport Complex IV; Glioma; Nigericin; Oxidation-Reduction; Oximetry; Protein Transport; Proton-Translocating ATPases; Rats; Resveratrol; Spectrophotometry; Stilbenes; Subcellular Fractions; Wheat Germ Agglutinins | 2011 |
Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells.
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Gene Knockdown Techniques; Glioma; Histones; Humans; Mice; Mice, Nude; Resveratrol; Stilbenes; Ubiquitin-Protein Ligases; Ubiquitination; Xenograft Model Antitumor Assays | 2011 |
Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Glioma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Reactive Oxygen Species; Resveratrol; Stilbenes; Temozolomide; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Resveratrol acts as a topoisomerase II poison in human glioma cells.
Topics: Antigens, Neoplasm; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Glioma; Histones; Humans; Models, Molecular; Protein Kinases; Protein Serine-Threonine Kinases; Resveratrol; Stilbenes; Topoisomerase II Inhibitors; Tumor Suppressor Proteins | 2012 |
Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Collagen; Drug Combinations; Gene Expression Regulation, Neoplastic; Glioma; Humans; Laminin; Neoplasm Invasiveness; NF-kappa B; Proteoglycans; Receptors, Urokinase Plasminogen Activator; Resveratrol; RNA, Messenger; Stilbenes; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 2011 |
Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Division; Cell Line; Cell Line, Tumor; Disease Models, Animal; Endothelium, Vascular; Flow Cytometry; Glioma; Kinetics; Neovascularization, Pathologic; Rats; Resveratrol; Stilbenes; Umbilical Veins | 2004 |
Resveratrol-induced apoptotic death in human U251 glioma cells.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspase 9; Caspase Inhibitors; Caspases; Cell Cycle; Cell Line, Tumor; Cytochromes c; Cytoplasm; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Glioma; Humans; Kinetin; L-Lactate Dehydrogenase; Phenols; Poly(ADP-ribose) Polymerases; Polyphenols; Proto-Oncogene Proteins c-bcl-2; Purines; Resveratrol; Signal Transduction; Stilbenes; Subcellular Fractions; Time Factors; Up-Regulation | 2005 |
High salt culture conditions suppress proliferation of rat C6 glioma cell by arresting cell-cycle progression at S-phase.
Topics: Animals; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Culture Media; Early Growth Response Protein 1; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Glioma; Hypertonic Solutions; Irinotecan; Osmolar Concentration; Rats; Resveratrol; S Phase; Sodium Chloride; Stilbenes | 2005 |
Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells.
Topics: Amyloid beta-Peptides; Animals; Antioxidants; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Down-Regulation; Glioma; Neuroglia; Neuroprotective Agents; NF-kappa B; Nitric Oxide Synthase Type II; Protein Transport; Rats; Resveratrol; Stilbenes; Transcriptional Activation | 2006 |
Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Caspases; Cell Line; Cell Survival; Comet Assay; DNA Damage; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Necrosis; Rats; Resveratrol; Stilbenes | 2006 |
Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Glioma; Glutamate-Ammonia Ligase; Glutamic Acid; Rats; Resveratrol; Stilbenes | 2006 |
Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Fibroblasts; Flow Cytometry; Glioma; In Situ Nick-End Labeling; Mice; Rats; Resveratrol; Stilbenes | 2007 |
Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells.
Topics: Analysis of Variance; Animals; Antioxidants; Cell Line, Tumor; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Drug Interactions; Glioma; Hydrogen Peroxide; Mice; Oxidative Stress; Propidium; Resveratrol; Stilbenes | 2007 |
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated.
Topics: Apoptosis; Brain Neoplasms; Cyclooxygenase 2; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glioma; Humans; Integrin alphaVbeta3; Phosphorylation; Protein Kinase C; Resveratrol; Stilbenes; Thyroxine | 2008 |